We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer (TH V THL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01526369
Recruitment Status : Terminated
First Posted : February 3, 2012
Last Update Posted : May 31, 2017
Information provided by (Responsible Party):
Cancer Trials Ireland

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : November 2015
  Estimated Study Completion Date : December 2017